Please assess the completion status of the following clinical trial:

Trial Title: Metformin in Intracytoplasmic Sperm Injection Cycles

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* First or second trial ICSI cycle.~* Age: 20 -38 years~* BMI: patients with BMI ≥ 30 kg/m2 were advised to lose weight for 6 months through lifestyle modifications.~* AMH ≥1 ng/ml~* Basal FSH \< 10 IU/ml.~* Normal uterine cavity evidenced by HSG or office hysteroscopy~* Normal levels of prolactin and TSH before starting COS cycle~Exclusion Criteria:~* Patients with recurrent two or more failed intra-cytoplasmic sperm injection cycles.~* Uterine anomalies or Synechiae.~* Severe male factor infertility~* Patients known to have diabetes, renal, liver disease, alcoholism, or drug abuse were excluded~* Patients who were on metformin treatment were asked to have a one month washout period before study participation.~* Poor responders

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: f

Study Arms:
- Metformin group (Type: ACTIVE_COMPARATOR): None
- Placebo group (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).